Business
STERIS Declares Dividend of $0.57 per share
DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and servic
About this update from Steris Plc (ireland)
[{"type":"image","alt":"STERIS plc","displaySize":"","headline":null,"caption":"STERIS plc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":49,"url":"https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_V2VVDc8.9gnCQDp8k6Yag--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/61c0b036d78c693a74a778c5841207dc","width":300,"height":49}},"lazy":false},{"type":"text","content":"DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025.","length":309,"tagName":"p"},{"type":"text","content":"Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com.","length":131,"tagName":"p"},{"type":"text","content":"STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.","length":277,"tagName":"p"},{"type":"text","content":"Company Contact: ","length":16,"tagName":"p"},{"type":"text","content":"Julie Winter, Vice President, Investor Relations and Corporate Communications","length":77,"tagName":"p"},{"type":"text","content":"[email protected]","length":23,"tagName":"p"},{"type":"text","content":"+1.440.392.7245","length":15,"tagName":"p"},{"type":"text","content":"CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION","length":58,"tagName":"p"},{"type":"text","content":"This release may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to STERIS or its industry, products or activities that are intended to qualify for the protections afforded “forward-looking statements” under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date the statement is made and may be identified by the use of forward-looki...